Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

NCT01374841 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Neoplasms

Interventions

DRUG: Cyclophosphamide
OTHER: Hematopoietic Stem Cell Transplantation,

Sponsor

European Institute of Oncology